Ashley Hall Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

RPHM Quotes by TradingView

Ashley Hall is Chief Development Officer of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 39,600 shares of RPHM, which is worth approximately $66,528. The most recent transaction as insider was on Aug 28, 2023, when has been sold 15,625 shares (Common Stock) at a price of $6.28 per share, resulting in proceeds of $98,125. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.6K
0% 3M change
0% 12M change
Total Value Held $66,528

Ashley Hall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 28 2023
SELL
Open market or private sale
$98,125 $6.28 p/Share
15,625 Reduced 28.29%
39,600 Common Stock
Aug 28 2023
BUY
Exercise of conversion of derivative security
$28,125 $1.8 p/Share
15,625 Added 22.05%
55,225 Common Stock
Nov 12 2021
BUY
Grant, award, or other acquisition
-
30,000 Added 50.0%
30,000 Common Stock

Also insider at

ESPR
Esperion Therapeutics, Inc. Healthcare
Chief Development Officer
GPCR
Structure Therapeutics Inc.
Chief Development Officer
AH

Ashley Hall

Chief Development Officer
Ann Arbor, MI

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPHM